These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38947012)

  • 1. Anti-tumor Effects of the eIF4A Inhibitor Didesmethylrocaglamide and Its Derivatives in Human and Canine Osteosarcomas.
    Oblinger J; Wang J; Wetherell G; Agarwal G; Wilson T; Benson N; Fenger J; Fuchs J; Kinghorn AD; Chang L
    Res Sq; 2024 Jun; ():. PubMed ID: 38947012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas.
    Oblinger JL; Wang J; Wetherell GD; Agarwal G; Wilson TA; Benson NR; Fenger JM; Fuchs JR; Kinghorn AD; Chang LS
    Sci Rep; 2024 Aug; 14(1):19349. PubMed ID: 39164287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.
    Chang LS; Oblinger JL; Burns SS; Huang J; Anderson LW; Hollingshead MG; Shen R; Pan L; Agarwal G; Ren Y; Roberts RD; O'Keefe BR; Kinghorn AD; Collins JM
    Mol Cancer Ther; 2020 Mar; 19(3):731-741. PubMed ID: 31848295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
    Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
    Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the targeting spectrum of rocaglates among eIF4A homologs.
    Naineni SK; Cencic R; Robert F; Brown LE; Haque M; Scott-Talib J; Sénéchal P; Schmeing TM; Porco JA; Pelletier J
    RNA; 2023 Jun; 29(6):826-835. PubMed ID: 36882295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis.
    Lizardo MM; Hughes C; Huang YZ; Shyp T; Delaidelli A; Zhang HF; Shaool SS; Renner AF; Burwag F; Sayles LC; Lee AG; Sweet-Cordero A; Sorensen PH
    Clin Cancer Res; 2024 Oct; 30(19):4464-4481. PubMed ID: 39078310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma.
    Kayastha F; Herrington NB; Kapadia B; Roychowdhury A; Nanaji N; Kellogg GE; Gartenhaus RB
    Mol Med; 2022 Sep; 28(1):101. PubMed ID: 36058921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A parasitic fungus employs mutated eIF4A to survive on rocaglate-synthesizing
    Chen M; Kumakura N; Saito H; Muller R; Nishimoto M; Mito M; Gan P; Ingolia NT; Shirasu K; Ito T; Shichino Y; Iwasaki S
    Elife; 2023 Feb; 12():. PubMed ID: 36852480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates.
    Obermann W; Azri MFD; Konopka L; Schmidt N; Magari F; Sherman J; Silva LMR; Hermosilla C; Ludewig AH; Houhou H; Haeberlein S; Luo MY; Häcker I; Schetelig MF; Grevelding CG; Schroeder FC; Lau GSK; Taubert A; Rodriguez A; Heine A; Yeo TC; Grünweller A; Taroncher-Oldenburg G
    Sci Rep; 2023 Jun; 13(1):9297. PubMed ID: 37291191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
    Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness.
    Sridharan S; Robeson M; Bastihalli-Tukaramrao D; Howard CM; Subramaniyan B; Tilley AMC; Tiwari AK; Raman D
    Front Oncol; 2019; 9():1311. PubMed ID: 31867270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA helicase, eIF4A-1, is required for ovule development and cell size homeostasis in Arabidopsis.
    Bush MS; Crowe N; Zheng T; Doonan JH
    Plant J; 2015 Dec; 84(5):989-1004. PubMed ID: 26493293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DEAD-box RNA helicase eIF4A regulates plant development and interacts with the hnRNP LIF2L1 in Physcomitrella patens.
    Tyagi V; Parihar V; Malik G; Kalra V; Kapoor S; Kapoor M
    Mol Genet Genomics; 2020 Mar; 295(2):373-389. PubMed ID: 31781862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
    Iwasaki S; Floor SN; Ingolia NT
    Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics.
    Taroncher-Oldenburg G; Müller C; Obermann W; Ziebuhr J; Hartmann RK; Grünweller A
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33807988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
    Chu J; Zhang W; Cencic R; Devine WG; Beglov D; Henkel T; Brown LE; Vajda S; Porco JA; Pelletier J
    Cell Chem Biol; 2019 Nov; 26(11):1586-1593.e3. PubMed ID: 31519508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
    J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.
    Waldron JA; Tack DC; Ritchey LE; Gillen SL; Wilczynska A; Turro E; Bevilacqua PC; Assmann SM; Bushell M; Le Quesne J
    Genome Biol; 2019 Dec; 20(1):300. PubMed ID: 31888698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells.
    Howard CM; Bearss N; Subramaniyan B; Tilley A; Sridharan S; Villa N; Fraser CS; Raman D
    Front Oncol; 2019; 9():284. PubMed ID: 31106142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.